Press Releases
FRANKFURT, Germany – Ashland Specialty Ingredients , a commercial unit of Ashland Inc. (NYSE: ASH), is today showcasing its expanded excipient portfolio and global R&D capabilities that support the formulation development goals of pharmaceutical companies.
FRANKFURT, Germany – Manufacturers of nutraceutical oral dosage forms now have more coating choices with the launch of the Aquarius™ coatings natural colors palette from Ashland Specialty Ingredients , a commercial unit of Ashland Inc. (NYSE: ASH). Label friendly and in compliance with food
WILMINGTON, Del. – Ashland Specialty Ingredients , a commercial unit of Ashland Inc. (NYSE: ASH), today announced three Benecel™ hypromellose (HPMC) excipients are now available for the formulation of matrix tablets. These commercial grades of intermediate-molecular-weight polymers deliver more
FRANKFURT, Germany - Ashland Specialty Ingredients , a commercial unit of Ashland Inc. (NYSE: ASH), today announced it will add a Good Manufacturing Process (GMP) hot-melt extruder in its Columbia, Md., USA, R&D center to better serve pharmaceutical companies working with poorly soluble drug
Ashland Specialty Ingredients is focused on health and wellness at Europe food expo WILMINGTON, Del. – Healthier foods that deliver on a wellness promise can be difficult for food processors to achieve, but ingredient innovations from Ashland Specialty Ingredients , a commercial unit of Ashland
New chemical advancements to coatings and construction industries for India and Asia markets
BARENDRECHT, Netherlands – Valvoline International Inc., an affiliate of Ashland Consumer Markets, a commercial unit of Ashland Inc. (NYSE: ASH), is shifting its distribution agreements for Eastern European countries to companies with more localized distribution operations.
FOR IMMEDIATE RELEASE: Oct. 13, 2011 COVINGTON, Ky. - Ashland Inc. (NYSE: ASH) today announced that on Wednesday, Nov. 9 , at 9 a.m. EST , it will conduct a live webcast of its fourth-quarter earnings presentation to the investment community. The presentation will cover results for the quarter
Ashland Inc. to present research on key challenges in pharmaceutical formulation development WILMINGTON, Del. – Ashland Specialty Ingredients , a commercial unit of Ashland Inc . (NYSE: ASH), today announced that it will present new research on excipients and tablet coatings at the American
Ashland expands global Natrosol™ hydroxyethylcellulose production WILMINGTON, Del.– Ashland Inc. (NYSE: ASH) is responding to strong demand for Natrosol™ hydroxyethylcellulose (HEC) by expanding HEC production across its global network through capacity additions at its facilities in Nanjing, China,